E13.0 Category · further specificity required Other specified diabetes mellitus with hyperosmolarity

ICD-10-CM E13.0 identifies “Other specified diabetes mellitus with hyperosmolarity” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 4: Endocrine, nutritional and metabolic diseases

Code-level instructions

No additional notes.

Inherited instructions

E13 · Other specified diabetes mellitus

Includes5
  • diabetes mellitus due to genetic defects of beta-cell function
  • diabetes mellitus due to genetic defects in insulin action
  • postpancreatectomy diabetes mellitus
  • postprocedural diabetes mellitus
  • secondary diabetes mellitus NEC
Excludes 17
  • diabetes (mellitus) due to autoimmune process (E10.-)
  • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • type 1 diabetes mellitus (E10.-)
Use additional code5
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)

Excludes 11

transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Note1

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

More specific codes

Official index references
History

Code history

Latest recorded change · FY2025

ChangedUnchanged
FY2025

Effective from

  • Inherited rules changed

Other specified diabetes mellitus with hyperosmolarity

Category — select a more specific code

CDC/NCHS · FY2025

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01Inherited rules changed
FY20182017-10-01Inherited rules changed
FY20192018-10-01No tabular change
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01Inherited rules changed
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change

Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.